More than for most businesses, shortening the time needed to bring a new product to market is vitally important for medical device companies. Given the industry’s rapid development of new technologies leading to steady improvements in functions and materials, the existing models of many devices are soon obsolete, ready to be replaced by next-generation products….

Hoping to increase competitiveness and improve patient outcomes, Taiwan’s hospitals are investing in high-value medical devices and artificial intelligence. But finding a balance between state-of-the-art equipment and affordable services remains a challenge. Despite continuous increases in the National Health Insurance (NHI) budget and raised premiums, Taiwan’s hospitals face progressively strained finances and stiff competition. To…

For more than 130 years, Johnson & Johnson has created value for patients, customers, employees, and shareholders through the development and provision of innovative products and solutions. As one of the largest and most diversified healthcare companies in the world, J&J has been able to devote significant resources to research and development across its three…

Edwards Lifesciences’ expertise in cardiovascular technology is highly specialized but essential for patients. The company focuses on treating critical conditions and diseases such as aortic stenosis, an unrecognized and undertreated, yet deadly, noncommunicable disease. In Asia, as few as around 2-3% of patients receive lasting treatment in the form of a heart valve replacement. “Around…

An annual report lists Taiwan-related trade issues being followed in Washington. Early each year, the Office of the U.S. Trade Representative (USTR) releases a country-by-country Report on Foreign Trade Barriers. The nine-page Taiwan section for 2020 provides a concise statement of the main areas of U.S.-government concern regarding elements of the bilateral trade relationship. Taiwan’s…